SCHEMBL76069

SCHEMBL76069

CCOP(=O)(OCC)On1nnc2ccccc2c1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 3/20 0.49
RAB9A P51151 3/20 0.49
ALDH1A1 P00352 4/20 0.49
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 2/20 0.43
HPGD P15428 2/20 0.43
MAPT P10636 2/20 0.43
TSHR P16473 2/20 0.43
HSD17B10 Q99714 2/20 0.43
KDM4E B2RXH2 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALOX15 P16050 1/20 0.43
MAPK1 P28482 1/20 0.43
HPSE Q9Y251 1/20 0.43
POLB P06746 1/20 0.43
KMT2A Q03164 2/20 0.43
MEN1 O00255 1/20 0.43
GPR139 Q6DWJ6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29394827 1.00 SMN1; SMN2 (0.49) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2
SCHEMBL22597948 0.89 POLB (0.43) SMN1; SMN2NPC1RAB9AALDH1A1LMNA
SCHEMBL17973539 0.88 ALDH1A1 (0.48) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2
SCHEMBL17839910 0.87 ALDH1A1 (0.49) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2
SCHEMBL4576394 0.87 ALDH1A1 (0.47) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2
SCHEMBL18507798 0.85 ALDH1A1 (0.49) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2
SCHEMBL6256744 0.84 NPC1 (0.37) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2
SCHEMBL1058740 0.83 ALDH1A1 (0.51) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2
SCHEMBL6254890 0.82 GPR139 (0.39) SMN1; SMN2NPC1RAB9AALDH1A1HPGD
SCHEMBL266156 0.82 TSHR (0.48) SMN1; SMN2NPC1RAB9ALMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3029 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577274-B2 Manufacture of glucagon peptides BACHEM HOLDING AG (CH) 2026-03-17 US claimed
US-20250346595-A1 GLP-1R Agonist and Therapeutic Method Thereof ASCLETIS PHARMA CHINA CO LTD (CN) 2025-11-13 US claimed
EP-4622991-A2 SYNTHESIS OF A CYCLIC PEPTIDE Janssen Pharmaceutica NV (BE) 2025-10-01 EP claimed
EP-4619408-A1 THE SYNTHESIS OF OMAPATRILAT Endothelium Scanning Nanotechnology Limited (AU) 2025-09-24 EP claimed
US-12398114-B2 Process for the preparation of ELIGLUSTAT and its intermediate PIRAMAL PHARMA LIMITED (IN) 2025-08-26 US claimed
EP-3676265-B1 METHOD FOR THE SYNTHESIS OF CYCLIC DEPSIPEPTIDES ELANCO ANIMAL HEALTH GMBH (DE) 2025-08-20 EP claimed
WO-2025149985-A1 METHODS OF PREPARING MELANOCORTIN 4 RECEPTOR AGONISTS LG CHEM, LTD. (KR) 2025-07-17 WO claimed
EP-4585268-A2 SOLID FORMS OF ISOQUINOLINONE DERIVATIVES, PROCESS OF MAKING, COMPOSITIONS COMPRISING, AND METHODS OF USING THE SAME Twelve Therapeutics, Inc. (US) 2025-07-16 EP claimed
CN-120118085-A Preparation method of Milvexian 中国药科大学 2025-06-10 CN claimed
WO-2025098464-A1 INTERMEDIATE FOR PREPARING GLUCAGON AND GLP-1 DUAL AGONIST AND PREPARATION METHOD THEREFOR INNOVENT BIOLOGICS (SUZHOU) CO., LTD. (CN) 2025-05-15 WO claimed
US-20080221303-A1 Method for the Preparation of Peptide-Oligonucleotide Conjugates FRUTAROM LTD. (IL) 2008-09-11 US claimed
US-20080086011-A1 Processes for the preparation of N-(2-acetyl-4,6-dimethylphenyl)-3-{[(3,4 dimethyl-5-isoxazolyl)amino[sulfonyl}-2-thiophenecarboxamide ENCYSIVE PHARMACEUTICALS, INC. 2008-04-10 US claimed
US-20080086010-A1 Processes for the preparation of 4-chloro-3-methyl-5-(2-(2-(6-methylbenzo[d][1,3]dioxol-5-yl)acetyl)-3-thienylsulfonamido)isoxazole ENCYSIVE PHARMACEUTICALS, INC. 2008-04-10 US claimed
WO-2008019074-A1 PROCESSES FOR THE PREPARATION OF 4-CHLORO-3-METHYL-5-(2-(2-(6-METHYLBENZO[D][1,3]DIOXOL-5-YL)ACETYL)-3-THIENYLSULFONAMIDO) ISOXAZOLE ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-02-14 WO claimed
WO-2008019096-A1 PROCESSES FOR THE PREPARATION OF N-(2-ACETYL-4,6-DIMETHYLPHENYL)-3-{[(3,4 DIMETHYL-5-ISOXAZOLYL)AMINO}SULFONYL}-2-THIOPHENECARBOXAMIDE ENCYSIVE PHARMACEUTICALS, INC. (US) 2008-02-14 WO claimed
EP-1725250-A2 METHOD FOR THE PREPARATION OF PEPTIDE-OLIGONUCLEOTIDE CONJUGATES FRUTAROM LTD. (IL) 2006-11-29 EP claimed
WO-2005076744-A2 METHOD FOR THE PREPARATION OF PEPTIDE-OLIGONUCLEOTIDE CONJUGATES FRUTAROM LTD. (IL) 2005-08-25 WO claimed
EP-1556039-A2 PROCESS FOR THE PREPARATION OF TRI-NITROGEN CONTAINING HETEROARYL-DIAMINE DERIVATIVES USEFUL AS PHARMACEUTICAL AGENTS AND METHODS OF PRODUCING PHARMACEUTICAL AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-07-27 EP claimed
US-20040077878-A1 Process for the preparation of tri-nitrogen containing heteroaryl-diamine derivatives useful as pharmaceutical agents and methods of producing pharmaceutical agents LIU CHUNJIAN (US) 2004-04-22 US claimed
WO-2004032875-A2 PROCESS FOR THE PREPARATION OF TRI-NITROGEN CONTAINING HETEROARYL-DIAMINE DERIVATIVES USEFUL AS PHARMACEUTICAL AGENTS AND METHODS OF PRODUCING PHARMACEUTICAL AGENTS BRISTOL-MYERS SQUIBB COMPANY (US) 2004-04-22 WO claimed